Recombinant vaccine against lyme disease

Details Recombinant vaccine against lyme disease Recombinant vaccine against lyme disease

C - Chemistry, Metallurgy

07

K

C07K 14/20 (2006.01) A61K 39/02 (2006.01) A61K 39/40 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2123121

2123121 9310237 PCTABS00022 A highly-antigenic, recombinant polypeptide of a molecular weight of about 110-kD by SDS-PAGE is disclosed, which is derived by transforming E. coli with a 7.1 kB DNA fragment from EcoR1-digested B. burgdorferi DNA, followed by identification of cloned transformants expressing polypeptides which bind to anti-B. burgdorferi antibodies.

Affiliated with

Also associated with

Rating

Recombinant vaccine against lyme disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant vaccine against lyme disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccine against lyme disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1834187